ArticleAnnals of medicine2025

The impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer.

Yiwen Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.